The experimental drug is similar to the Boston-based company’s recently approved pill Journavx but could potentially be given ...

Peripheral neuropathy affects millions, often leaving people feeling frustrated, dismissed, and stuck with symptoms like ...

Dr. Evan Norum, DC, BCN, founder of Advantage Neuropathy, joins us on The Morning Blend to discuss treatments for neuropathy.

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...